rs587776931
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_020699.4(GATAD2B):c.1408C>T(p.Gln470*) variant causes a stop gained change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_020699.4 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GATAD2B | NM_020699.4 | c.1408C>T | p.Gln470* | stop_gained | Exon 8 of 11 | ENST00000368655.5 | NP_065750.1 | |
GATAD2B | XM_047426115.1 | c.1411C>T | p.Gln471* | stop_gained | Exon 8 of 11 | XP_047282071.1 | ||
GATAD2B | XM_047426117.1 | c.1408C>T | p.Gln470* | stop_gained | Exon 8 of 11 | XP_047282073.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GATAD2B | ENST00000368655.5 | c.1408C>T | p.Gln470* | stop_gained | Exon 8 of 11 | 1 | NM_020699.4 | ENSP00000357644.4 | ||
GATAD2B | ENST00000634544.1 | c.1408C>T | p.Gln470* | stop_gained | Exon 8 of 11 | 5 | ENSP00000489184.1 | |||
GATAD2B | ENST00000634408.1 | c.1360C>T | p.Gln454* | stop_gained | Exon 8 of 11 | 5 | ENSP00000489595.1 | |||
GATAD2B | ENST00000634564.1 | c.661C>T | p.Gln221* | stop_gained | Exon 3 of 5 | 5 | ENSP00000489309.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Inborn genetic diseases Pathogenic:1
The alteration results in a premature stop codon: _x000D_ _x000D_ The c.1408C>T (p.Q470*) alteration, located in exon 8 (coding exon 7) of the GATAD2B gene, results from a C to T substitution at nucleotide position 1408. This changes the amino acid from a glutamine (Q) to a stop codon at amino acid position 470. This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. The alteration is not observed in population databases: _x000D_ _x000D_ Based on data from the Genome Aggregation Database (gnomAD), the GATAD2B c.1408C>T alteration was not observed, with coverage at this position. The alteration has been observed in affected individuals:_x000D_ _x000D_ This alteration was previously detected de novo in two unrelated patients with intellectual disability (de Ligt, 2012; Kosmicki, 2017). Based on the available evidence, this alteration is classified as pathogenic. -
not provided Pathogenic:1
Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 28191890, 35982159, 23644463, 23033978, 34470925, 30482549, 24896178) -
Severe intellectual disability-poor language-strabismus-grimacing face-long fingers syndrome Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at